3-[2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol structure
|
Common Name | 3-[2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol | ||
|---|---|---|---|---|
| CAS Number | 73809-05-9 | Molecular Weight | 400.63700 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H44O2 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 57.2 °F | |
| Symbol |
GHS02, GHS07 |
Signal Word | Danger | |
| Name | 3-[2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol |
|---|---|
| Synonym | More Synonyms |
| Molecular Formula | C27H44O2 |
|---|---|
| Molecular Weight | 400.63700 |
| Exact Mass | 400.33400 |
| PSA | 40.46000 |
| LogP | 6.73390 |
| Symbol |
GHS02, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H319 |
| Precautionary Statements | P210-P280-P305 + P351 + P338-P337 + P313-P403 + P235 |
| RIDADR | UN1170 - class 3 - PG 2 - Ethanol, solution |
| Flash Point(F) | 57.2 °F |
| Flash Point(C) | 14 °C |
|
Dietary resistant starch prevents urinary excretion of 25-hydroxycholecalciferol and vitamin D-binding protein in type 1 diabetic rats.
J. Nutr. 143(7) , 1123-8, (2013) Diabetes is a rapidly growing epidemic affecting millions of Americans and has been implicated in a number of devastating secondary complications. We previously demonstrated that type 2 diabetic rats ... |
|
|
25-hydroxvitamin D3 promotes the long-term effect of specific immunotherapy in a murine allergy model.
J. Immunol. 193(3) , 1017-23, (2014) Calcitriol (1α,25-dihydroxyvitamin D3) is the active vitamin D metabolite and mediates immunological functions, which are relevant in allergy. Its therapeutic use is limited by hypercalcaemic toxicity... |
|
|
Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab.
J. Clin. Oncol. 32(29) , 3242-8, (2014) To investigate the impact and mechanisms of vitamin D deficiency (VDD) on the outcome of elderly patients with diffuse large B-cell lymphoma (DLBCL).Three hundred fifty-nine pretreatment 25-hydroxyvit... |
| (3s)-9,10-secocholesta-5,7,10-triene-3,25-diol |
| 3-Epi-25-Hydroxyvitamin D3 |
| 25-Hydroxycholecalciferol |
| 25-Hydroxy-vitamin D3 |
| (1S,3Z)-3-[(2E)-2-[(1R,7aR)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol |